Table 1.
Enrichment by pathway maps
| Maps | Gene Ratio | p-value | FDR | Gene |
|---|---|---|---|---|
| IL-1 signaling in melanoma | 6/42 | 1.097E-10 | 4.092E-08 | GRO-1, GRO-2, MMP-1, COX-2 (PTGS2), IL-6, ICAM1 |
| Interleukins-induced inflammatory response in asthmatic airway fibroblasts | 5/35 | 4.636E-09 | 8.647E-07 | GRO-1, GRO-2, COX-2 (PTGS2), IL-6, ICAM1 |
| Immune response_IL-1 signaling pathway | 6/82 | 6.981E-09 | 8.680E-07 | GRO-1, MMP-1, COX-2 (PTGS2), IL-6, ICAM1, MMP-13 |
| Immune response_IL-17 signaling pathways | 5/60 | 7.564E-08 | 7.053E-06 | GRO-1, MMP-1, COX-2 (PTGS2), IL-6, ICAM1 |
| Inflammatory mechanisms of pancreatic cancerogenesis | 5/67 | 1.326E-07 | 9.892E-06 | GRO-1, COX-2 (PTGS2), IL-6, ICAM1, IL-32 (NK4) |
| Cigarette smoke-induced inflammatory signaling in airway epithelial cells | 4/36 | 5.394E-07 | 3.353E-05 | COX-2 (PTGS2), IL-6, ICAM1, sICAM1 |
| Glomerular injury in Lupus Nephritis | 5/92 | 6.547E-07 | 3.489E-05 | GRO-1, GRO-2, MMP-1, IL-6, ICAM1 |
| Release of pro-inflammatory factors and proteases by alveolar macrophages in asthma | 4/44 | 1.231E-06 | 5.738E-05 | GRO-1, GRO-2, MMP-1, IL-6 |
| Immune response_Histamine H1 receptor signaling in immune response | 4/47 | 1.611E-06 | 6.677E-05 | MMP-1, IL-6, ICAM1, MMP-13 |
| Activation of TNF-alpha-dependent pro-tumoral effect in colorectal cancer | 4/49 | 1.909E-06 | 7.120E-05 | GRO-1, COX-2 (PTGS2), IL-6, ICAM1 |
| Immune response_IL-18 signaling | 4/63 | 5.274E-06 | 1.788E-04 | IL-18R1, COX-2 (PTGS2), IL-6, ICAM1 |
| TNF-alpha and IL-1 beta-mediated regulation of contraction and secretion of inflammatory factors in normal and asthmatic airway smooth muscle | 4/65 | 5.979E-06 | 1.859E-04 | GRO-1, GRO-2, COX-2 (PTGS2), IL-6 |